About US
Contact us
-
PaxVax receives US marketing approval from FDA for cholera vaccineUS-based biotechnology company PaxVax has received marketing approval from the US Food and Drug Administration (FDA) for cholera vaccine, Vaxchora. The single-dose oral, live attenuated cholera vacci2016/6/14
-
Merck signs definitive agreement to buy US firm Afferent PharmaceuticalsUS drug company Merck has signed a definitive agreement to acquire privately held US-based clinical-stage biotechnology company Afferent Pharmaceuticals. Known as Merck Sharp & Dohme (MSD) outsid2016/6/13
-
Report: Crisaborole to benefit from the merger between Pfizer and AnacorThe $5.2bn impending merger between Pfizer and Anacor is expected to accelerate the marketing and commercialisation of Anacor's atopic dermatitis pipeline candidate Crisaborole, according to a report2016/6/13
-
Thailand certified to be free of mother-to-child HIV transmissionThe Ministry of Public Health has officially declared Thailand to be the first country in Asia to be free of the transmission of human immunodeficiency virus (HIV) and syphilis from mothers to their i2016/6/12
-
Cancer Research UK to develop new bubbly drink for effective cancer treatmentScientists from Cancer Research UK are developing a drink that is packed with oxygen microbubbles with an aim to provide more potential treatment for hard-to-treat tumours such as pancreatic cancer.2016/6/12
-
Genisphere and AstraZeneca’s MedImmune ink R&D, licensing dealPennsylvania nanotech company Genisphere and AstraZeneca’s ($AZN) biologics R&D company MedImmune have agreed to formalize a collaboration on research with an option to license nanoparticles using2016/6/8
-
Phillips-Medisize buys Denmark’s Medicom Innovation, expanding European presencePhillips-Medisize, a medical injection molder, bought Denmark’s Medicom Innovation Partner, a provider of device strategy, product design and drug delivery systems, in a move to expand its footprint i2016/6/8
-
Novavax presents data on developing seasonal influenza nanoparticles for RSVUS-based, clinical-stage vaccine company Novavax has presented data for the company's nanoparticle programme at the New Approaches to Vaccines for Human and Veterinary Tropical Diseases Keystone Sympo2016/6/7
-
Novartis and Eisai to promote Lenvima in combination with everolimus to treat RCCSwitzerland's Novartis Pharmaceuticals has entered into an agreement with Japanese firm Eisai's US subsidiary to co-promote Lenvima (lenvatinib) capsules in combination with everolimus, to treat patie2016/6/7
-
Filling Semi-solids into Syringes in a Clean, Accurate, and Space-Saving MannerConventional filling techniques in the pharmaceutical industry often see semi-solid and viscous products such as ointments, gels, and creams applied via a dosing syringe. However, the quantities requi2016/6/6